Page last updated: 2024-09-05

organophosphonates and dihydropyridines

organophosphonates has been researched along with dihydropyridines in 4 studies

Compound Research Comparison

Studies
(organophosphonates)
Trials
(organophosphonates)
Recent Studies (post-2010)
(organophosphonates)
Studies
(dihydropyridines)
Trials
(dihydropyridines)
Recent Studies (post-2010) (dihydropyridines)
9,9688803,5965,022529969

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haruta, Y; Kandori, K; Kimura, K; Kise, M; Morita, I; Tomita, T; Tsuda, M1
Holý, A; Kmonícková, E; Potmesil, P; Zídek, Z1
Holý, A; Kmonícková, E; Krecmerová, M; Potmesil, P; Zídek, Z1
Gong, LZ; Jiang, J; Rao, QQ; Sun, XX; Yu, J1

Other Studies

4 other study(ies) available for organophosphonates and dihydropyridines

ArticleYear
Syntheses and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. III.
    Chemical & pharmaceutical bulletin, 1987, Volume: 35, Issue:12

    Topics: Animals; Antihypertensive Agents; Chemical Phenomena; Chemistry; Dihydropyridines; Male; Organophosphonates; Rats; Rats, Inbred SHR; Rats, Inbred Strains

1987
Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine.
    European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2

    Topics: 2-Aminopurine; Adenine; Adjuvants, Immunologic; Animals; Anti-HIV Agents; Caffeine; Cell Survival; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Dihydropyridines; Dose-Response Relationship, Drug; Female; Flavins; Humans; Interleukin-10; Lipopolysaccharides; Macrophage Inflammatory Proteins; Macrophages; Mice; Mice, Inbred C57BL; Molecular Structure; Organophosphonates; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Theophylline; Triazoles; Tumor Necrosis Factor-alpha

2006
Nucleotide analogues with immunobiological properties: 9-[2-Hydroxy-3-(phosphonomethoxy)propyl]-adenine (HPMPA), -2,6-diaminopurine (HPMPDAP), and their N6-substituted derivatives.
    European journal of pharmacology, 2006, Jul-01, Volume: 540, Issue:1-3

    Topics: Adenine; Animals; Caffeine; Cell Survival; Cytokines; Dihydropyridines; Dose-Response Relationship, Drug; Female; Gene Expression; Interferon-gamma; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Nucleotides; Organophosphonates; Organophosphorus Compounds; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triazoles

2006
Organocatalytic asymmetric three-component cyclization of cinnamaldehydes and primary amines with 1,3-dicarbonyl compounds: straightforward access to enantiomerically enriched dihydropyridines.
    Angewandte Chemie (International ed. in English), 2008, Volume: 47, Issue:13

    Topics: Acrolein; Amines; Biological Products; Catalysis; Cyclization; Dihydropyridines; Ketoses; Models, Chemical; Organophosphonates; Piperidines; Stereoisomerism

2008